经导管三尖瓣缘对缘修复对重度三尖瓣反流患者右心室逆重构的影响
本研究为前瞻性单中心队列研究,纳入34例重度三尖瓣反流患者,评估经导管三尖瓣缘对缘修复(T-TEER)后右心室逆重构及临床疗效。结果显示术后9个月所有患者三尖瓣反流减少≥2级,右心室尺寸减小、功能改善,NYHA心功能均为Ⅰ/Ⅱ级,无主要心脑血管不良事件,初步证实T-TEER安全有效。
要点
- T-TEER术后9个月所有患者三尖瓣反流减少≥2级,79%为轻中度。
- 术后9个月右心室舒张末期内径、三尖瓣环左右径均较基线减小。
- 术后9个月三尖瓣环收缩期位移和右心室面积变化分数均较基线增加。
核心结论
- 初步证实T-TEER治疗重度三尖瓣反流安全有效,术后9个月患者右心室逆重构较明显。
研究设计与样本
- 前瞻性单中心队列研究,纳入2021年3月至2023年6月厦门大学附属心血管病医院诊断为重度三尖瓣反流的患者34例。
- 所有患者术前接受经胸超声心动图和经食管三维超声心动图检查,术后30天、6个月、9个月接受经胸超声心动图检查。
- 主要终点为心脑血管不良事件,包括死亡、卒中、心肌梗死、再手术、心律失常、传导阻滞。
主要发现
- 共纳入34例患者,年龄(67.9±9.3)岁,71%(24/34)为女性,中位随访时间9个月。
- 术后9个月所有患者三尖瓣反流减少≥2级,79%(27/34)为轻中度三尖瓣反流。
- 术后9个月三尖瓣反流束缩流颈宽度(5.42±2.33)mm vs.(11.54±4.05)mm,P<0.001;有效反流口面积(0.24±0.09)cm² vs.(0.52±0.14)cm²,P<0.001;反流束面积(7.95±4.02)cm² vs.(13.93±6.10)cm²,P<0.001。
- 术后9个月下腔静脉内径(19.38±2.63)mm vs.(23.56±3.31)mm,P<0.001;右心室舒张末期内径(28.03±6.26)mm vs.(33.21±8.24)mm,P=0.001;三尖瓣环左右径(36.47±4.40)mm vs.(41.44±7.08)mm,P<0.001,均较基线减小。
- 术后9个月三尖瓣环收缩期位移(18.08±5.25)mm vs.(14.91±3.42)mm,P=0.005;右心室面积变化分数(37.61±7.52)% vs.(30.79±9.06)%,P=0.004,均较基线增加。
临床怎么用
- 对于重度三尖瓣反流患者,T-TEER可显著减少三尖瓣反流并促进右心室逆重构,术后9个月心功能改善且无主要不良事件。
局限性
- 本研究为单中心、小样本(34例)前瞻性队列研究,随访时间较短(中位9个月),结论需更大样本和更长随访验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To quantitatively analyze right ventricular reverse remodeling in patients with severe tricuspid regurgitation after transcatheter tricuspid edge-to-edge repair (T-TEER) by two-dimensional speckle tracking echocardiography, and to preliminarily evaluate the clinical efficacy of this procedure. Methods: This study was a prospective single-center cohort study. Patients diagnosed with severe tricuspid regurgitation at the Xiamen Cardiovascular Hospital Xiamen University from March 2021 to June 2023 were enrolled. All patients underwent transthoracic echocardiography and transesophageal three-dimensional echocardiography before T-TEER, and transthoracic echocardiography at 30 days, 6 months, and 9 months after T-TEER. The primary endpoint was major adverse cardiovascular and cerebrovascular events, including death, stroke, myocardial infarction, reoperation, arrhythmia, and conduction block. Other clinical evaluation indicators included New York Heart Association (NYHA) functional classification and tricuspid regurgitation grade. Results: A total of 34 patients were enrolled, aged (67.9±9.3) years, and 71% (24/34) were female. The median follow-up duration was 9 months. All patients achieved a reduction of tricuspid regurgitation by ≥2 grades at 9 months after T-TEER, with 79% (27/34) of them having mild to moderate tricuspid regurgitation. Transthoracic echocardiography at 9 months after T-TEER showed that the vena contracta width of tricuspid regurgitation ((5.42±2.33) mm vs. (11.54±4.05) mm, P<0.001), effective regurgitant orifice area ((0.24±0.09) cm² vs. (0.52±0.14) cm², P<0.001), regurgitant jet area ((7.95±4.02) cm² vs. (13.93±6.10) cm², P<0.001), inferior vena cava diameter ((19.38±2.63) mm vs. (23.56±3.31) mm, P<0.001), right ventricular end-diastolic diameter ((28.03±6.26) mm vs. (33.21±8.24) mm, P=0.001), and tricuspid annular diameter ((36.47±4.40) mm vs. (41.44±7.08) mm, P<0.001) were all reduced compared with baseline; while the tricuspid annular plane systolic excursion ((18.08±5.25) mm vs. (14.91±3.42) mm, P=0.005) and right ventricular fractional area change ((37.61±7.52)% vs. (30.79±9.06)%, P=0.004) were both increased compared with baseline. At 9 months after T-TEER, all patients had a NYHA functional classification of grade Ⅰ or Ⅱ, and no major adverse cardiovascular and cerebrovascular event occurred during the follow-up period. Conclusion: It is preliminarily confirmed that T-TEER is safe and effective in the treatment of severe tricuspid regurgitation, with significant right ventricular reverse remodeling observed in patients at 9 months after T-TEER. 目的: 应用二维斑点追踪技术定量分析重度三尖瓣反流患者经导管三尖瓣缘对缘修复(T-TEER)后的右心室逆重构,并初步评估其临床疗效。 方法: 本研究为前瞻性单中心队列研究。选取2021年3月至2023年6月在厦门大学附属心血管病医院诊断为重度三尖瓣反流的患者。所有患者在T-TEER术前接受经胸超声心动图和经食管三维超声心动图检查,在T-TEER术后30 d及术后6、9个月进行经胸超声心动图检查。主要终点事件为心脑血管不良事件,包括死亡、卒中、心肌梗死、再手术、心律失常、传导阻滞,其他临床评价指标有纽约心脏协会(NYHA)心功能分级、三尖瓣反流分级。 结果: 共纳入34例患者,年龄(67.9±9.3)岁,71%(24/34)为女性。中位随访时间为9个月。所有患者在T-TEER术后9个月三尖瓣反流减少≥2级,79%(27/34)三尖瓣反流为轻中度。T-TEER术后9个月的经胸超声心动图数据显示,三尖瓣反流束缩流颈宽度[(5.42±2.33)mm比(11.54±4.05)mm,P<0.001]、有效反流口面积[(0.24±0.09)cm2比(0.52±0.14)cm2,P<0.001]、反流束面积[(7.95±4.02)cm2比(13.93±6.10)cm2,P<0.001]、下腔静脉内径[(19.38±2.63)mm比(23.56±3.31)mm,P<0.001]、右心室舒张末期内径[(28.03±6.26)mm比(33.21±8.24)mm,P=0.001]、三尖瓣环左右径[(36.47±4.40)mm比(41.44±7.08)mm,P<0.001]均较基线减小;三尖瓣环收缩期位移[(18.08±5.25)mm比(14.91±3.42)mm,P=0.005]、右心室面积变化分数[(37.61±7.52)%比(30.79±9.06)%,P=0.004]均较基线增加。T-TEER术后9个月患者的NYHA心功能分级均为Ⅰ/Ⅱ级,随访期间无心脑血管不良事件。 结论: 初步证实T-TEER治疗重度三尖瓣反流安全有效,T-TEER术后9个月患者的右心室逆重构较明显。.
引用
- Tang YR, Chen X, Wang B, et al. [The effect of transcatheter edge-to-edge repair on right ventricular reverse remodeling in patients with severe tricuspid regurgitation]. Zhonghua Xin Xue Guan Bing Za Zhi. 2025. PMID: 41139649. doi:10.3760/cma.j.cn112148-20231031-00401
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。